Skip to main content
. 2021 Aug 21;13(8):e17355. doi: 10.7759/cureus.17355

Table 2. Treatment results.

Data encompassing treatment results, hospital stay, morbidity, and mortality are provided as mean (range). 

*Overall postoperative morbidity includes surgical infections, seizures, postoperative bleeds, new neurologic deficits, and misplaced catheters. Morbidity numbers are compared at the time of hospital discharge.

†Mortality and recurrence numbers are for all follow-up.

MLS: Midline shift.

Treatment Results IRRAflow
Hematoma size at 24h 13.4 (11.0-20.0)
Change in hematoma size 11.0 (5.0-16.0)
MLS at 24h 5.71 (0.0-7.0)
Change in midline shift 3.14 (3.0-7.0)
Length of stay 2.67 (2.0-4.0)
ICU days 1.83 (1.0-3.0)
Days with surgical drain 1.41 (1.0-3.0)
Morbidity/Mortality                  N (%)
Overall postoperative morbidity* 0 (0%)
Mortality 0 (0%)
Recurrence 0 (0%)